← Today in private wealth · North America

U.S. funding week: Science raises $400 million and Linq becomes a unicorn.

Why it mattersFive U.S. health and biotech companies drew more than $750 million in fresh equity, while Linq’s unicorn round shows investors are also backing the infrastructure that lets AI agents reach customers.

Neurotechnology led the U.S. funding brief for the week of 16 November 2026. Science Corporation, founded by Max Hodak, Alan Mardinly and Emma Zhou, raised $400 million to advance its retinal implant and neural-interface technology. TechCrunch reported a $3.5 billion valuation for the existing unicorn. At that valuation, assumed stakes of 10%, 5% and 5% imply paper values of $350 million, $175 million and $175 million, respectively. The ownership assumptions carry very low confidence. (TechCrunch)

Linq, founded by Elliott Potter, Patrick Sullivan and Jared Mattsson, reached a $1 billion valuation after a $90 million Series B for its AI messaging and voice infrastructure. Assumed stakes of 12%, 8% and 8% imply paper values of $120 million, $80 million and $80 million, respectively. The founders’ actual holdings remain undisclosed. (Linq)

Health and biotech also drew $130 million for Jonathan Waldstreicher and William Krimsky’s Galvanize Therapeutics, $87 million for Theodore Randolph and Robert Garcea’s VitriVax, $71.5 million for Ansa Biotechnologies, and $62 million for David Bell and Jake Sganga’s Remedy Robotics. Hone Health, led by co-founder Saad Alam, announced a $228 million package, comprising $28 million in Series A equity and $200 million in growth financing (Hone Health announcement).

Elsewhere, Yejin Choi and Carlos Guestrin’s Noeri launched with $110 million, automotive retail software provider VINCUE secured $93 million, and Chang She and Lei Xu’s LanceDB raised $57.5 million.

Sources

    Compiled by the Private Wealth Institute from 0 sources.

    More from North America.

    All North America news